2026-01-24 - Analysis Report
# Halliburton Company (HAL) Analysis Report

## 1. Stock Performance Comparison

* Ticker: HAL, Company Name: Halliburton
* Cumulative return of review stock: 35.69%
* Cumulative return of comparison stock (S&P 500, VOO): 126.41%
* Divergence: -90.70 (max: 33.90, min: -132.80, relative divergence: 25.30%)
* The review stock underperformed the comparison stock with a higher divergence, indicating a possible risk.

## 2. Recent Stock Price Fluctuations

* Close price: $33.95
* 5-day SMA: $33.13
* 20-day SMA: $31.22
* 60-day SMA: $28.59
* Recent price fluctuations indicate a short-term decrease in prices with a sharp rebound.

## 3. RSI, PPO Index, and Delta Analysis

* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* RSI: 69.97
* PPO: 0.35
* Recent (20 days) relative divergence change: 3.50 (+)
* 7-day Rank change: -7 (-)
* 7-day Dynamic Expected Return change: -350.30 (-)
* The current MRI indicates a medium investment risk, but other indicators suggest a sharp rebound or sharp decline.

## 4. Recent News & Significant Events

* S&P 500 oilfield services titan Halliburton tops earnings but everyone is focused on Venezuela.
* Hara Capital LLC trims stock holdings in Halliburton Company $HAL.
* HAL shares in focus on signing deal for LCA Mk1A engines with GE.
* Did Halliburtonâ€™s (HAL) earnings beat and Venezuela plans just recast its international growth story?
* Citigroup raises Halliburton (HAL) price target, reaffirms buy rating.
* I Like Halliburton (HAL), says Jim Cramer.

## 5. Analyst Opinions

* Analyst Consensus:
 * Key: Buy
 * Mean (1=StrongBuy~5=Sell): 1.96 (~Buy)
 * Opinions: 25
 * Target Price (avg/high/low): 35.58 / 46.48 / 28.00

## Comprehensive Analysis

The recent stock price fluctuations and divergence analysis suggest a possible underperformance of Halliburton compared to its peers and the comparison stock. However, the analyst opinions and news suggest a possible growth story and a buy rating, despite the sharp rebound or decline in recent days. The medium investment risk level and hybrid signal indicators suggest caution is warranted. Based on the analysis, it is recommended to review and reassess the investment strategy for Halliburton Company.

---

### Alpha, Beta Analysis | Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|------|-------|-------|
| 2016-2018  | -28.0% | 41.3% | -40.0% | 1.2 | 22.7B |
| 2017-2019  | -69.0% | 45.1% | -94.0% | 1.1 | 20.9B |
| 2018-2020  | -53.0% | 80.1% | -77.0% | 1.7 | 16.1B |
| 2019-2021  | 16.0% | 79.8% | -49.0% | 1.8 | 19.5B |
| 2020-2022  | 92.0% | 77.9% | 85.0% | 1.6 | 33.5B |
| 2021-2023  | 71.0% | 43.7% | 50.0% | 1.0 | 30.8B |
| 2022-2024  | -19.0% | 43.7% | -49.0% | 0.8 | 23.2B |
| 2023-2025  | -50.0% | 47.3% | -125.0% | 1.1 | 24.1B |

---

### Detailed Alpha, Beta Analysis Summary

The table above shows the historical performance of Halliburton Company. The company experienced various returns, from a loss of 28% to a gain of 92%. The CAGR ranged from 41.3% to 80.1%, while the MDD ranged from 40.0% to 94.0%. The alpha was positive in some years and negative in others, ranging from -40.0% to 85.0%. The beta also fluctuated, ranging from 0.8 to 1.8. Overall, the company's performance has been volatile, but the recent years showed a trend towards growth.

---

### Price Movement

As shown below, the prices of Halliburton Company have fluctuated significantly over the recent years. The 60-day, 20-day, and 5-day SMA have shown a downward trend, indicating a possible decrease in prices over the short-term.

* Close price (2026-01-24): $33.95
* 5-day SMA: $33.13
* 20-day SMA: $31.22
* 60-day SMA: $28.59

---

### RSI, PPO Index, and Delta Analysis

The market risk indicator (MRI) indicated a medium investment risk, while the RSI and PPO indices suggested a possible sharp rebound or sharp decline. The recent relative divergence change showed an improvement, but the 7-day rank change and dynamic expected return change showed a worsening trend.

* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* RSI: 69.97
* PPO: 0.35
* Recent (20 days) relative divergence change: 3.50 (+)
* 7-day Rank change: -7 (-)
* 7-day Dynamic Expected Return change: -350.30 (-)

---

### Expected Return

The expected return analysis suggested a negative expected return for the short-term. Additionally, the expected return compared to the S&P 500 index showed a high expected excess return.

* Expected Return: -124.90%
* Expected excess return compared to S&P 500: N/A (more than 2 years)

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.